Hims & Hers to Offer $450 Million in Convertible Notes to Fuel Global Growth and AI Investment

Hims & Hers Health announced a proposed private offering of $450 million in convertible senior notes due 2030, with an option for an additional $67.5 million. Proceeds will support global expansion, strategic acquisitions, and deeper investment in AI, diagnostics, and personalized treatments.

The company plans to settle conversions with cash, stock, or both and may redeem the notes starting in 2028 under certain conditions. A portion of proceeds will fund capped call transactions to minimize share dilution. The offering is limited to qualified institutional buyers and is not registered under the Securities Act.

Hims & Hers Health, Inc. has announced that Chief Operating Officer Melissa Baird will be transitioning into an advisory role with the company. While the exact date of her departure has not been determined, she plans to remain in her current role until a successor is identified, appointed, and fully acclimated. Upon her transition, the company and Baird will enter into a long-term agreement, allowing Hims & Hers to continue benefiting from her expertise and experience.